Jazz Pharmaceuticals
JAZZ
#2102
Rank
NZ$12.81 B
Marketcap
$211.92
Share price
4.55%
Change (1 day)
6.09%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.13

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.40. In 2022 the company made an earnings per share (EPS) of -$6.02 an increase over its 2021 EPS that were of -$9.15.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-64.58%
2022-$6.02-34.2%
2021-$9.15-224.83%
2020$7.33-53.25%
2019$15.6723.59%
2018$12.68-8.24%
2017$13.8223.74%
2016$11.1722.12%
2015$9.15478.49%
2014$1.58-74.93%
2013$6.31-27.11%
2012$8.6569.1%
2011$5.12245.98%
2010$1.48-462.5%
2009-$0.41-96.7%
2008-$12.38-27.04%
2007-$16.9665.47%
2006-$10.25-4.59%
2005-$10.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.83 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$14.09-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.36-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.40 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel